重组水蛭素主治手术后血栓形成、体外循环、血管成形术、深静脉血栓形成等。
作为直接凝血酶抑制剂，重组水蛭素在临床上的应用已越来越重要。
As a direct thrombin inhibitor, recombinant hirudin (r-hirudin) has played an important role in clinical use.
结果所制备的重组水蛭素肠溶包衣微丸药物含量质量分数为3.513%。
Results The drug content of prepared recombinant hirudin coated-pellets was 3.513% (w).
结论重组水蛭素经蟾蜍肺泡膜的转运是一个非能量依赖、非载体依赖的被动扩散过程。
CONCLUSION The transport of recombinant hirudin across xenopus pulmonary membrane was a passive diffusion process which was energy-independent and carrier-independent.
应用推荐